Roux-en-Y gastric bypass vs sleeve gastrectomy in super obesity: a systematic review and meta-analysis
| Autor: | Hugo Santos-Sousa, Raquel Bouça-Machado, Sofia Raquel Gomes-Rocha, Silvestre Carneiro, Jorge Nogueiro, Carolina Coelho Pais-Neto, John Preto, André de Araújo Pereira, Eduardo Jorge Lima-da-Costa, André Costa-Pinho |
|---|---|
| Přispěvatelé: | Repositório da Universidade de Lisboa |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Sleeve gastrectomy
medicine.medical_specialty Weight loss Endocrinology Diabetes and Metabolism medicine.medical_treatment Gastric bypass LRYGB Super obesity Laparoscopic Roux-en-Y gastric bypass LSG medicine Comorbidity resolution Bariatric surgery Laparoscopic sleeve gastrectomy Nutrition and Dietetics business.industry medicine.disease Roux-en-Y anastomosis Surgery Meta-analysis medicine.symptom business Dyslipidemia |
| Zdroj: | Repositório Científico de Acesso Aberto de Portugal Repositório Científico de Acesso Aberto de Portugal (RCAAP) instacron:RCAAP |
| Popis: | © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG) are safe procedures that may present sub-optimal results in superobesity (SO). A meta-analysis was performed aiming to summarize the available evidence on weight loss (primary outcome) and comorbidities resolution of LRYGB and LSG in patients with SO (BMI ≥ 50 kg/m2). From the 16 included studies, 7 integrated the meta-analysis. LRYGB showed a significantly higher weight loss at 6 to 12-months, but not after 24 months and a higher dyslipidemia resolution at 12 months. When compared with LSG, LRYGB achieved better weight loss after 6 and 12 months and higher dyslipidemia resolution after 1 year. There were no significant differences for resolution of the other co-morbidities studied. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|